Filarial nematode secreted product ES-62 is an anti-inflammatory agent: Therapeutic potential of small molecule derivatives and ES-62 peptide mimetics

被引:42
作者
Harnett, W
Harnett, MM
机构
[1] Univ Strathclyde, Dept Immunol, Glasgow G4 0NR, Lanark, Scotland
[2] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow, Lanark, Scotland
基金
英国惠康基金;
关键词
ES-62; filarial nematodes; inflammation; signal transduction;
D O I
10.1111/j.1440-1681.2006.04400.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The 'hygiene hypothesis' postulates that the recent increased incidence of allergic or autoimmune diseases (e.g. asthma, type I diabetes) in the West reflects an absence of appropriate priming of the immune response by infectious agents, such as parasitic worms, during childhood. 2. Consistent with this, it has long been recognized that several autoimmune disorders, such as rheumatoid arthritis (RA), a T helper (Th) 1-mediated autoimmune disease characterized by excess production of pro-inflammatory cytokines, such as tumour necrosis factor-a, exhibit reduced incidence and severity in geographical regions with high parasite load, suggesting that environmental factors may subtly alter disease progression. 3. Infection with worms also appears to suppress Th2-biased inflammatory disorders, such as asthma, because there also appears to be an inverse correlation between parasite load and atopy. This is perhaps more surprising, given that helminths often induce strong Th2-type immune responses characterized by release of specific cytokines, such as interleukin (IL)-4, IL-5 and IL-13. 4. Therefore, these findings suggest that the co-evolution of helminths with hosts, which has resulted in the ability of worms to modulate inflammatory responses in order to promote parasite survival, may also have generated a predisposition for the host to develop autoimmunity and allergy in the absence of infection. 5. The mechanisms underlying such immunomodulation are not clear, but appear to involve the release of parasite-derived molecules that allow the worms to modulate or evade the host immune response by a number of mechanisms, including skewing of cytokine responses and the induction of T regulatory cells. 6. In the present review we discuss the properties of one such filarial nematode-derived immunomodulatory molecule, namely ES-62, its anti-inflammatory action and the therapeutic potential of small molecule derivatives and peptides that mimic its action.
引用
收藏
页码:511 / 518
页数:8
相关论文
共 95 条
[1]   19 Å solution structure of the filarial nematode immunomodulatory protein, ES-62 [J].
Ackerman, CJ ;
Harnett, MM ;
Harnett, W ;
Kelly, SM ;
Svergun, DI ;
Byron, O .
BIOPHYSICAL JOURNAL, 2003, 84 (01) :489-500
[2]  
Acosta D, 1998, J PARASITOL, V84, P1, DOI 10.2307/3284518
[3]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[4]   Proinflammatory cytokines dominate the early immune response to filarial parasites [J].
Babu, S ;
Nutman, TB .
JOURNAL OF IMMUNOLOGY, 2003, 171 (12) :6723-6732
[5]   The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK [J].
Barr, RK ;
Boehm, I ;
Attwood, PV ;
Watt, PM ;
Bogoyevitch, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (35) :36327-36338
[6]   RHEUMATOID-ARTHRITIS IN A RURAL SOUTH-AFRICAN NEGRO POPULATION [J].
BEIGHTON, P ;
SOLOMON, L ;
VALKENBURG, HA .
ANNALS OF THE RHEUMATIC DISEASES, 1975, 34 (02) :136-141
[7]   IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells [J].
Belladonna, ML ;
Renauld, JC ;
Bianchi, R ;
Vacca, C ;
Fallarino, F ;
Orabona, C ;
Fioretti, MC ;
Grohmann, U ;
Puccetti, P .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5448-5454
[8]   C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI) [J].
Bodman-Smith, KB ;
Melendez, AJ ;
Campbell, I ;
Harrison, PT ;
Allen, JM ;
Raynes, JG .
IMMUNOLOGY, 2002, 107 (02) :252-260
[9]   Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential [J].
Bogoyevitch, MA ;
Boehm, I ;
Oakley, A ;
Ketteman, AJ ;
Barr, RK .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1697 (1-2) :89-101
[10]   Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death [J].
Bonny, C ;
Oberson, A ;
Negri, S ;
Sauser, C ;
Schorderet, DF .
DIABETES, 2001, 50 (01) :77-82